rs551397
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000186.4(CFH):c.59-36C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.273 in 1,542,258 control chromosomes in the GnomAD database, including 67,908 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.40 ( 15261 hom., cov: 32)
Exomes 𝑓: 0.26 ( 52647 hom. )
Consequence
CFH
NM_000186.4 intron
NM_000186.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.145
Publications
19 publications found
Genes affected
CFH (HGNC:4883): (complement factor H) This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]
CFH Gene-Disease associations (from GenCC):
- primary membranoproliferative glomerulonephritisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- atypical hemolytic-uremic syndromeInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- hemolytic uremic syndrome, atypical, susceptibility to, 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- complement factor H deficiencyInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- basal laminar drusenInheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- Doyne honeycomb retinal dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dense deposit diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 1-196672942-C-T is Benign according to our data. Variant chr1-196672942-C-T is described in ClinVar as Benign. ClinVar VariationId is 1209735.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.711 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CFH | NM_000186.4 | c.59-36C>T | intron_variant | Intron 1 of 21 | ENST00000367429.9 | NP_000177.2 | ||
| CFH | NM_001014975.3 | c.59-36C>T | intron_variant | Intron 1 of 9 | NP_001014975.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CFH | ENST00000367429.9 | c.59-36C>T | intron_variant | Intron 1 of 21 | 1 | NM_000186.4 | ENSP00000356399.4 | |||
| ENSG00000289697 | ENST00000696032.1 | c.59-36C>T | intron_variant | Intron 1 of 26 | ENSP00000512341.1 |
Frequencies
GnomAD3 genomes AF: 0.398 AC: 60359AN: 151790Hom.: 15215 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
60359
AN:
151790
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.313 AC: 74917AN: 239220 AF XY: 0.303 show subpopulations
GnomAD2 exomes
AF:
AC:
74917
AN:
239220
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.260 AC: 360929AN: 1390350Hom.: 52647 Cov.: 22 AF XY: 0.259 AC XY: 180272AN XY: 695552 show subpopulations
GnomAD4 exome
AF:
AC:
360929
AN:
1390350
Hom.:
Cov.:
22
AF XY:
AC XY:
180272
AN XY:
695552
show subpopulations
African (AFR)
AF:
AC:
22951
AN:
31300
American (AMR)
AF:
AC:
16572
AN:
43730
Ashkenazi Jewish (ASJ)
AF:
AC:
6731
AN:
25590
East Asian (EAS)
AF:
AC:
16104
AN:
38936
South Asian (SAS)
AF:
AC:
26268
AN:
83992
European-Finnish (FIN)
AF:
AC:
15652
AN:
53064
Middle Eastern (MID)
AF:
AC:
1154
AN:
5632
European-Non Finnish (NFE)
AF:
AC:
239215
AN:
1050242
Other (OTH)
AF:
AC:
16282
AN:
57864
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
11908
23816
35725
47633
59541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8390
16780
25170
33560
41950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.398 AC: 60471AN: 151908Hom.: 15261 Cov.: 32 AF XY: 0.399 AC XY: 29656AN XY: 74244 show subpopulations
GnomAD4 genome
AF:
AC:
60471
AN:
151908
Hom.:
Cov.:
32
AF XY:
AC XY:
29656
AN XY:
74244
show subpopulations
African (AFR)
AF:
AC:
29753
AN:
41452
American (AMR)
AF:
AC:
5945
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
936
AN:
3468
East Asian (EAS)
AF:
AC:
2185
AN:
5152
South Asian (SAS)
AF:
AC:
1578
AN:
4818
European-Finnish (FIN)
AF:
AC:
3124
AN:
10512
Middle Eastern (MID)
AF:
AC:
46
AN:
292
European-Non Finnish (NFE)
AF:
AC:
15883
AN:
67926
Other (OTH)
AF:
AC:
755
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1532
3065
4597
6130
7662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1504
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Factor H deficiency Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hemolytic uremic syndrome, atypical, susceptibility to, 1 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Age related macular degeneration 4 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Basal laminar drusen Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.